Amlodipine may be worth it for patients with CAD . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 501, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cardiac resynchronisation therapy worth it in heart failure

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Statins: pleitropic effects of any benefit in CAD?

By  

Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration

By Patmore L.   Fraser S.   Mair D.   Templeton A.  

European Journal of Pharmacology, Vol. 406, Iss. 3, 2000-10 ,pp. : 449-452

Elsevier

Access to resources Recommend Favorite

Action-Potential Duration and Contractility in Canine Cardiac Tissues - dependence on shortening of action potential duration and reduction of intracellular sodium activity

By Nanasi P.P.   Varro A.   Lathrop D.A.  

General Pharmacology, Vol. 31, Iss. 3, 1998-09 ,pp. : 415-418

Elsevier

Access to resources Recommend Favorite